BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32452110)

  • 1. Donor insulin use predicts beta-cell function after islet transplantation.
    Shapey IM; Summers A; Yiannoullou P; Khambalia H; Fullwood C; Hanley NA; Casey J; Forbes S; Rosenthal M; Johnson PR; Choudhary P; Bushnell J; Shaw JAM; Augustine T; Rutter MK; van Dellen D
    Diabetes Obes Metab; 2020 Oct; 22(10):1874-1879. PubMed ID: 32452110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor insulin therapy in intensive care predicts early outcomes after pancreas transplantation.
    Shapey IM; Summers A; Khambalia H; Yiannoullou P; Fullwood C; Hanley NA; Augustine T; Rutter MK; van Dellen D
    Diabetologia; 2021 Jun; 64(6):1375-1384. PubMed ID: 33665687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell death and dysfunction drives hyperglycaemia in organ donors.
    Shapey IM; Summers A; O'Sullivan J; Fullwood C; Hanley NA; Casey J; Forbes S; Rosenthal M; Johnson PRV; Choudhary P; Bushnell J; Shaw JAM; Neiman D; Shemer R; Glaser B; Dor Y; Augustine T; Rutter MK; van Dellen D
    Diabetes Obes Metab; 2023 Dec; 25(12):3529-3537. PubMed ID: 37646197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of our first nine intraportal islet allografts in type 1, insulin-dependent diabetic patients.
    Scharp DW; Lacy PE; Santiago JV; McCullough CS; Weide LG; Boyle PJ; Falqui L; Marchetti P; Ricordi C; Gingerich RL
    Transplantation; 1991 Jan; 51(1):76-85. PubMed ID: 1987709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry.
    Chetboun M; Drumez E; Ballou C; Maanaoui M; Payne E; Barton F; Kerr-Conte J; Vantyghem MC; Piemonti L; Rickels MR; Labreuche J; Pattou F;
    Lancet Diabetes Endocrinol; 2023 Jun; 11(6):391-401. PubMed ID: 37105208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple evaluation of engraftment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation.
    Matsumoto S; Yamada Y; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Nakai Y; Ueda M; Ishii A; Yabunaka E; Tanaka K
    Transplant Proc; 2005 Oct; 37(8):3435-7. PubMed ID: 16298620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasting parameters for estimation of stimulated β cell function in islet transplant recipients with or without basal insulin treatment.
    Uitbeijerse BS; Nijhoff MF; Sont JK; de Koning EJP
    Am J Transplant; 2021 Jan; 21(1):297-306. PubMed ID: 32524720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry (CITR).
    Baidal DA; Ballou CM; Rickels MR; Berney T; Pattou F; Payne EH; Barton FB; Alejandro R;
    Diabetes Care; 2023 Apr; 46(4):697-703. PubMed ID: 36657975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity.
    Rickels MR; Kamoun M; Kearns J; Markmann JF; Naji A
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2410-4. PubMed ID: 17488791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.
    Brooks AM; Oram R; Home P; Steen N; Shaw JA
    Diabetes Care; 2015 Jan; 38(1):105-12. PubMed ID: 25422169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
    Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
    Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol.
    Ryan EA; Lakey JR; Rajotte RV; Korbutt GS; Kin T; Imes S; Rabinovitch A; Elliott JF; Bigam D; Kneteman NM; Warnock GL; Larsen I; Shapiro AM
    Diabetes; 2001 Apr; 50(4):710-9. PubMed ID: 11289033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glucagon-like peptide-1 on beta- and alpha-cell function in isolated islet and whole pancreas transplant recipients.
    Rickels MR; Mueller R; Markmann JF; Naji A
    J Clin Endocrinol Metab; 2009 Jan; 94(1):181-9. PubMed ID: 18957498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin independence of unstable diabetic patient after single living donor islet transplantation.
    Matsumoto S; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Yamada Y; Nakai Y; Ueda M; Ishii A; Yabunaka E; Shapiro JA; Tanaka K
    Transplant Proc; 2005 Oct; 37(8):3427-9. PubMed ID: 16298617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program.
    Forbes S; Flatt AJ; Bennett D; Crookston R; Pimkova M; Birtles L; Pernet A; Wood RC; Burling K; Barker P; Counter C; Lumb A; Choudhary P; Rutter MK; Rosenthal M; Sutherland A; Casey J; Johnson P; Shaw JAM
    Am J Transplant; 2022 Jan; 22(1):154-164. PubMed ID: 34355503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.
    Dufrane D; Maillart JF; Aouassar N; Goebbels RM; Guiot Y; Gianello P
    Xenotransplantation; 2009; 16(3):152-63. PubMed ID: 19566655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus.
    Warnock GL; Meloche RM; Thompson D; Shapiro RJ; Fung M; Ao Z; Ho S; He Z; Dai LJ; Young L; Blackburn L; Kozak S; Kim PT; Al-Adra D; Johnson JD; Liao YH; Elliott T; Verchere CB
    Arch Surg; 2005 Aug; 140(8):735-44. PubMed ID: 16103282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early efficacy of islet transplantation in the treatment of adult advanced diabetes].
    Hu AB; Ling XC; Duan JL; Liao WW; Zhu XF; He XS; Liu FR; Bai F
    Zhonghua Yi Xue Za Zhi; 2020 Jul; 100(26):2040-2043. PubMed ID: 32654450
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of donor age on islet isolation and transplantation outcome.
    Niclauss N; Bosco D; Morel P; Demuylder-Mischler S; Brault C; Milliat-Guittard L; Colin C; Parnaud G; Muller YD; Giovannoni L; Meier R; Toso C; Badet L; Benhamou PY; Berney T
    Transplantation; 2011 Feb; 91(3):360-6. PubMed ID: 21344706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine secretory reserve and proinsulin processing in recipients of islet of langerhans versus whole pancreas transplants.
    Elkhafif NM; Borot S; Morel P; Demuylder-Mischler S; Giovannoni L; Toso C; Bosco D; Berney T
    Diabetes Care; 2013 Nov; 36(11):3726-31. PubMed ID: 24041681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.